Citation Impact
Citing Papers
Vitamin D Deficiency and Risk of Cardiovascular Disease
2008 Standout
Annual Rate of Transvenous Defibrillation Lead Defects in Implantable Cardioverter-Defibrillators Over a Period of >10 Years
2007
Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study
2004
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Diet and Lifestyle Recommendations Revision 2006
2006 Standout
Pharmacotherapy for rhythm management in elderly patients with atrial fibrillation
2009
Clinical and Electrophysiologic Predictors of Ventricular Tachyarrhythmia Recurrence in Patients with Implantable Cardioverter Defibrillators
2003
Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment
2011
Effect of Fish Oil on Ventricular Tachyarrhythmia and Death in Patients With Implantable Cardioverter Defibrillators
2006
Mechanisms of Thrombus Formation
2008 Standout
Sudden death in idiopathic dilated cardiomyopathy
1992
What is the “Optimal” follow-up schedule for ICD patients?
2005
n–3 Fatty Acids in Cardiovascular Disease
2011
Chronotropic incompetence in young patients with late postoperative atrial flutter: a case-control study
2006
Association Between Omega-3 Fatty Acid Supplementation and Risk of Major Cardiovascular Disease Events
2012
Exercise Standards for Testing and Training
2013 Standout
Prognostic value of the signal-averaged electrocardiogram and a prolonged QRS in ischemic ana nonischemic cardiomyopathy
1995
Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines
2006
Efficacy and safety of catheter ablation versus antiarrhythmic drugs for atrial fibrillation: a meta-analysis of randomized trials
2010
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
2009 Standout
Implantable Cardioverter Defibrillator in High‐Risk Long QT Syndrome Patients
2003
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Acute coronary angiographic findings in survivors of out-of-hospital cardiac arrest
2008
Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy
1999
Global incidences of out-of-hospital cardiac arrest and survival rates: Systematic review of 67 prospective studies
2010 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Diseases
2009 Standout
Sudden death in hypertrophic cardiomyopathy: identification of high risk patients
2000
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
2013 Standout
Sudden cardiac death and channelopathies: a review of implantable defibrillator therapy
2004
Cardioverter-defibrillator implantation in high-risk patients with hypertrophic cardiomyopathy
2005
Implantable cardioverter-defibrillators are preferable to drugs as primary therapy in sustained ventricular tachyarrhythmias
1996
Regional Variation in Out-of-Hospital Cardiac Arrest Incidence and Outcome
2008 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Antiarrhythmic drugs versus implantable defibrillators: The need for a randomized controlled study
1994
Platelet Activation and Atherothrombosis
2007 Standout
First Documented Rhythm and Clinical Outcome From In-Hospital Cardiac Arrest Among Children and Adults
2006 Standout
Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation
2010
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices—Summary Article
2002
Fish Intake, Contaminants, and Human Health
2006 Standout
Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia
1996 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Myocarditis
2011 Standout
Efficacy of Implantable Cardioverter Defibrillator Therapy for Primary and Secondary Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
2003
The Role of Fish Oil in Arrhythmia Prevention
2008
Pharmacologic Management of Supraventricular Tachycardias in Children
1997
Sudden Cardiac Death in Hemodialysis Patients: An In-Depth Review
2011
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Subclinical Atrial Fibrillation and the Risk of Stroke
2012
Dietary intervention with oil rich fish reduces platelet-monocyte aggregation in man
2007
Implantable cardioverter defibrillator: Use in patients with no symptoms and at high risk
1996
Immediate Coronary Angiography in Survivors of Out-of-Hospital Cardiac Arrest
1997
Five-year experience with implantable defibrillators in children
1996
Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome
2007
Angiographic assessment of the culprit coronary artery lesion before acute myocardial infarction
1990
Radiofrequency Catheter Ablation as a Primary Therapy for Treatment of Ventricular Tachycardia in a Patient After Repair of Tetralogy of Fallot
1994
Stroke and thromboembolism in atrial fibrillation: A systematic review of stroke risk factors, risk stratification schema and cost effectiveness data
2008
Task Force on Sudden Cardiac Death of the European Society of Cardiology
2001
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary
2008
Antiarrhythmic Effects of Omega-3 Fatty Acids
2006
Prognosis Among Survivors of Prehospital Cardiac Arrest
1995
Epidemiology of syncope in hospitalized patients
1999
Hypertrophic Cardiomyopathy
2002 Standout
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Summary Article
2002
Implantable Cardioverter Defibrillator Therapy in Children with Long QT Syndrome
2004
Coronary lesion morphology in acute myocardial infarction: Demonstration of early remodeling after streptokinase treatment
1990
Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator
2002
Value of Programmed Ventricular Stimulation in Patients with Congenital Heart Disease
1999
INFLUENCE OF PLAQUE CONFIGURATION AND STRESS DISTRIBUTION ON FISSURING OF CORONARY ATHEROSCLEROTIC PLAQUES
1989
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis
1995 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Incidence and Prognosis of Syncope
2002 Standout
Cost-Effectiveness of Implantable Cardioverter–Defibrillators
2005
Omega-3 Fatty Acids for Cardioprotection
2008
Essential Features of Designating Out-of-Hospital Cardiac Arrest as a Reportable Event
2008
Association of Vitamin D Deficiency with Heart Failure and Sudden Cardiac Death in a Large Cross-Sectional Study of Patients Referred for Coronary Angiography
2008
Dietary Fish and n-3 Fatty Acid Intake and Cardiac Electrocardiographic Parameters in Humans
2006
Omega-3 Fatty Acids and Cardiovascular Disease
2011
Implantable cardioverter-defibrillator therapy in patients with congenital long-QT syndrome: A long-term follow-up
2005
n−3 Fatty acids from fish or fish-oil supplements, but not α-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review
2006
Complications of Implantable Cardioverter Defibrillator Therapy in 440 Consecutive Patients
2005
Establishing Arizona's Statewide Cardiac Arrest Reporting andEducational Network
2008
Antithrombotic Therapy for Atrial Fibrillation
2012
Guidelines on management (diagnosis and treatment) of syncope
2001
Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications
2008
Cardiovascular benefits of omega-3 fatty acids
2006
Demographic and temporal trends in out of hospital sudden cardiac death in Belfast
2005
Defibrillation Thresholds and Perioperative Mortality Associated with Endocardial and Epicardial Defihrillation Lead Systems
1993
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Myocarditis
2009 Standout
Evaluating and improving the cost-effectiveness of the implantable cardioverter—defibrillator
1995
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
Long-Term Follow-Up of Patients With Long-QT Syndrome Treated With β-Blockers and Continuous Pacing
1999
The Importance of the Omega-6/Omega-3 Fatty Acid Ratio in Cardiovascular Disease and Other Chronic Diseases
2008 Standout
HIF-1α is required for development of the sympathetic nervous system
2019 StandoutNobel
Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology.
1994 Standout
A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias
1997 Standout
QRS Fragmentation and Sudden Cardiac Death in the Obese and Overweight
2015
Acute Myocardial Infarction in Women
2016
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
2006
Results of the International Study of the Implantable Pacemaker Cardioverter-Defibrillator
1995
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death
2008
Part 9: Post–Cardiac Arrest Care
2010 Standout
Permanent Epicardial Pacing in Pediatric Patients
2001
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Long-Term Comparison of the Implantable Cardioverter Defibrillator Versus Amiodarone
2004
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Contemporary Definitions and Classification of the Cardiomyopathies
2006 Standout
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death
2008
Sudden Cardiac Death
1998 Standout
Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.
1994 Standout
Empirical Versus Tested Antitachycardia Pacing in Implantable Cardioverter Defibrillators
1998
Role of Transvenous Implantable Cardioverter-Defibrillators in Preventing Sudden Cardiac Death in Children, Adolescents, and Young Adults
2002
Epidemiology and Genetics of Sudden Cardiac Death
2012
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Physical Activity and Public Health in Older Adults
2007 Standout
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
2008
n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors
2013 Standout
CLINICAL GUIDELINE: Diagnosing Syncope: Part 2: Unexplained Syncope
1997
Coronary Plaque Disruption
1995 Standout
Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome
2007
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2006
Effectiveness and Limitations of β-Blocker Therapy in Congenital Long-QT Syndrome
2000
Prevention of stroke in patients with atrial fibrillation: current strategies and future directions
2008
Prevention of Fatal Arrhythmias in High-Risk Subjects by Fish Oil n-3 Fatty Acid Intake
2005
Part 14: Pediatric Advanced Life Support
2010 Standout
Immediate Percutaneous Coronary Intervention Is Associated With Better Survival After Out-of-Hospital Cardiac Arrest
2010
2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
Acute Administration of Fish Oil Inhibits Triggered Activity in Isolated Myocytes From Rabbits and Patients With Heart Failure
2008
Molecular Bases of the Acute Coronary Syndromes
1995 Standout
Works of Jack Kron being referenced
The automatic implantable cardioverter-defibrillator in young patients
1990
Preliminary Experience with Nonthoracotomy Implantahle Cardioverter Defihrillators in Young Patients
1994
Bradycardia-mediated tachyarrhythmias in congenital heart disease and responses to chronic pacing at physiologic rates
1990
Do baseline characteristics accurately discriminate between patients likely versus unlikely to benefit from implantable defibrillator therapy?
2001
Catecholamine-dependent ventricular tachycardia following repair of tetralogy of Fallot
1991
Use of Implantable Cardioverter-Defibrillators in the Congenital Long QT Syndrome
1996
Spontaneous sustained ventricular tachyarrhythmias during treatment with type IA antiarrhythmic agents
1990
Mechanisms of AV Node Reentrant Tachycardia in Young Patients With and Without Dual AV Node Physiology
1994
Current burden of sudden cardiac death: Multiple source surveillance versus retrospective death certificate-based review in a large U.S. community
2004
Lead- and device-related complications in the Antiarrhythmics Versus Implantable Defibrillators Trial
2001
Analysis of programmed stimulation methods in the evaluation of ventricular arrhythmias in patients 20 years old and younger
1990
Angiographic coronary morphology in survivors of cardiac arrest
1988
Use of the signal-averaged electrocardiogram for predicting inducible ventricular tachycardia in patients with unexplained syncope: Relation to clinical variables in a multivariate analysis
1994
Long-term multicenter experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias
1992
Fish Oil Supplementation and Risk of Ventricular Tachycardia and Ventricular Fibrillation in Patients With Implantable Defibrillators
2005
Idiopathic Dilated Cardiomyopathy
1988
Implantable cardioverter-defibrillator therapy in survivors of out-of-hospital sudden cardiac death without inducible arrhythmias
1993
Asymptomatic atrial fibrillation: Demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study
2005
Clinical Significance of Device-Related Complications in Clinical Trials and Implications for Future Trials: Insights from the Antiarrhytmics versus Implantable Defibrillators (AVID) Trial
2003
Analysis of Cause-Specific Mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study
2004